CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
Sign Up to like & getrecommendations! Published in 2020 at "Heliyon"
DOI: 10.1016/j.heliyon.2020.e04015
Abstract: Escitalopram (ESC), a selective serotonin reuptake inhibitor indicated for the treatment of depression and anxiety disorders, is primarily metabolized by cytochrome P450 (CYP) 2C19, which is a highly polymorphic enzyme known to cause inter-individual differences… read more here.
Keywords: depression; mirtazapine bupropion; treatment; polymorphisms outcomes ... See more keywords